Neuropathic pains caused by cancer. Other specified diabetes mellitus with diabetic neuropathic arthropathy
Conditions
Interventions
Intervention 1: Intervention group: Patients in this group will apply 10% gabapentin gel as a base cream (liposomal) to the pain site. They will be asked to clean the painful area and then massage 4 m
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: People aged between 18 and 75 years. Cancer patients undergoing the first course of Oxaliplatin treatment.
Exclusion criteria
Exclusion criteria: Pregnancy and breastfeeding. Patients with diabetic (type 1 and type 2 diabetic patients) neuropathy and trauma. Abuse of alcohol, drugs, and smoking. Taking painkillers routinely starting two weeks before beginning Gabapentin. History of chemotherapy with Taxane group drugs, including Paclitaxel (Taxol) and Docetaxel (Taxotere). Previous history of chemotherapy with Oxaliplatin drug. History of sensitivity to Gabapentin. People who have experienced neuropathic pain due to the same cancer before taking the drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Neuropathic pain. Timepoint: At the beginning of the study (before the start of the intervention), 14, 21, 35 days after starting the use of topical gabapentin. Method of measurement: Visual Analogue Scale (VAS) to assess patients' pain severity. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mohammad Sahebkar
Sabzevar University of Medical Sciences
Outcome results
None listed